healthcare economics
Beyond the Picket Line: A Financial Analysis of the UK Doctors’ Strike and Its Economic Shockwaves
A financial analysis of the UK junior doctors’ strike, exploring its deep economic impact on public finance, the stock market, and investor sentiment.
The Billion-Dollar Diagnosis: Why Autism’s ‘Dilemma’ is a Critical Economic Issue for Investors and Business Leaders
The “autism diagnosis dilemma” is not just a healthcare issue; it’s a critical economic problem with major implications for finance, investing, and business.
The Ozempic Price War: How a 71% Medicare Discount is Reshaping Healthcare Finance
A landmark 71% Medicare price cut on Ozempic and Wegovy signals a major shift in healthcare finance, impacting investors, the economy, and Big Pharma.
The Trillion-Dollar Bug: How AI and New Financial Models Are Fuelling the War on Superbugs
A new GSK-backed venture uses AI and innovative financial models to combat the growing economic and health threat of drug-resistant superbugs.
Merck’s Strategic Gambit: Why a Potential Deal for Cidara’s Flu Drug Could Reshape Preventative Medicine and Your Portfolio
Merck’s potential acquisition of Cidara Therapeutics signals a major shift in flu prevention, impacting healthcare, finance, and the broader economy.
Pharma’s High-Stakes Gamble: Inside the Pfizer vs. Novo Bidding War for a Weight-Loss Unicorn
A fierce bidding war erupts between Pfizer and Novo Nordisk for biotech firm Metsera, signaling a high-stakes battle for the future of the obesity drug market.
The Struldbrug’s Curse: Why the Finance World Must Rethink Longevity Investing
Extending life without health is an economic curse. The real investment opportunity lies in the “healthspan revolution,” not just the longevity market.
NHS plc: Could Trading Healthcare on the Stock Market Be the Ultimate Cure?
A radical proposal to float the UK’s NHS on the stock market. Could market forces and fintech be the cure for a struggling national healthcare system?